Microclots and Neutrophil Activation as Potential Indicators for Stroke Risk and Reperfusion Failure
Recruiting
Observational Study
Ischemic Stroke
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 500 (estimated)
- Sponsor
- University of Zurich · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Stroke remains a major health burden worldwide. Many patients are severely disabled and stay in need of care. Mechanical thrombectomy has dramatically improved outcomes for stroke patients with large vessel occlusions, yet 40-50% of patients with successful recanalization remain severely disabled despite successful recanalization, a scenario called "futile recanalization". One of the causes for th…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Patients without acute stroke CS or CSG
* No previous stroke or previous stroke ≥ 1 year ago
* Signed informed consent
Patients with acute stroke (AS-noTx, AS-IVT, AS-MT):
* Patients admitted with high suspicion of acute ischemic stroke
* Time of onset of stroke symptoms ≤ 12…
Contacts